Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera
Authors:
- 1 June 2017
- journal article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 41, 49-54
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Personalized management of essential thrombocythemia—application of recent evidence to clinical practiceLeukemia, 2013
- Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohortBlood, 2012
- Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteriaLeukemia, 2011
- Polycythemia vera‐associated acquired von Willebrand syndrome despite near‐normal platelet countAmerican Journal of Hematology, 2010
- Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand FactorScience, 2009
- Fluid Shear Induces Conformation Change in Human Blood Protein von Willebrand Factor in SolutionBiophysical Journal, 2009
- Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single‐centre cohort studyJournal of Thrombosis and Haemostasis, 2008
- Acquired von Willebrand syndrome: An updateAmerican Journal of Hematology, 2006
- Management of extreme thrombocytosis in otherwise low-risk essential thrombocythemia; does number matter?Blood, 2006
- The Paradox of Platelet Activation and Impaired Function: Platelet-von Willebrand Factor Interactions, and the Etiology of Thrombotic and Hemorrhagic Manifestations in Essential Thrombocythemia and Polycythemia VeraSeminars in Thrombosis and Hemostasis, 2006